Platelet Function Assays for the Diagnosis of Aspirin Resistance

References

• Van Oosterom N, Barras M, Bird R, Nusem I, Cottrell N. A narrative review of aspirin resistance in VTE prophylaxis for orthopaedic surgery. Drugs 2020;80(18):1889–1899. doi:10.1007/s40265-020-01413-w
   PubMed Web of Science ®Google Scholar
• Demir DM. Aspirin therapeutic uses, adverse effects and pharmacokinetics. Hauppauge, N.Y.:Nova Science Publishers; 2011.
   Google Scholar
• Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367(9510):606–617. doi:10.1016/S0140-6736(06)68040-9
   PubMed Web of Science ®Google Scholar
• Shim EJ, Ryu C-W, Park S, Lee HN, Shin HS, Kim S-B. Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis. J Neurointerv Surg 2018;10(10):942. doi:10.1136/neurintsurg-2017-013632
   PubMed Web of Science ®Google Scholar
• Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S. High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis. J Neurol Sci 2017;376:112–116. doi:10.1016/j.jns.2017.03.010
   PubMed Web of Science ®Google Scholar
• Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis. Br Med J 2008;336(7637):195. doi:10.1136/bmj.39430.529549.BE
   PubMed Web of Science ®Google Scholar
• Li J, Song M, Jian Z, Guo W, Chen G, Jiang G, Wang J, Wu X, Huang L. Laboratory aspirin resistance and the risk of major adverse cardiovascular events in patients with coronary heart disease on confirmed aspirin adherence. J Atheroscler Thromb 2014;21(3):239–247. doi:10.5551/jat.19521
   PubMed Web of Science ®Google Scholar
• Snoep JD, Hovens MMC, Eikenboom JCJ, van der Bom JG, Huisman MV. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007;167(15):1593–1599. doi:10.1001/archinte.167.15.1593
   PubMedGoogle Scholar
• Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF. Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events — a meta-analysis. Int J Cardiol 2008;128(2):166–171. doi:10.1016/j.ijcard.2007.12.010
   PubMed Web of Science ®Google Scholar
• Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 2005;3(6):1309–1311. doi:10.1111/j.1538-7836.2005.01351.x
   PubMed Web of Science ®Google Scholar
• Sun P, McMillan-Ward E, Mian R, Israels SJ. Comparison of light transmission aggregometry and multiple electrode aggregometry for the evaluation of patients with mucocutaneous bleeding. Int J Lab Hematol 2019;41(1):133–140. doi:10.1111/ijlh.12937
   PubMed Web of Science ®Google Scholar
• Würtz M, Hvas A-M, Kristensen SD, Grove EL. Platelet aggregation is dependent on platelet count in patients with coronary artery disease. Thromb Res 2011;129(1):56–61. doi:10.1016/j.thromres.2011.08.019
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Kristensen SD, Hvas A. Is the new point-of-care test VerifyNow (R) aspirin able to identify aspirin resistance using the recommended cut-off? Blood 2007;110(11):42B–42B. doi:10.1182/blood.V110.11.3896.3896
   Web of Science ®Google Scholar
• Piazza G, Hohlfelder B, Goldhaber SZ. Handbook for venous thromboembolism. Cham:Springer International Publishing; 2015.
   Google Scholar
• Michelson ADMD. Methods for the measurement of platelet function. Am J Cardiol 2009;103(3):20A–26A. doi:10.1016/j.amjcard.2008.11.019
   PubMedGoogle Scholar
• Liu T, Zhang J, Chen Y, Feng X, Wang L, Liu M. ASSA14-03-41 Platelet thromboxane 11-dehydro-Thromboxane B2 (11dhTxB2) and aspirin response and its correlation with clinical outcome in patients with Coronary artery disease and Diabetes. Heart 2015;101(Suppl 1):A23–A23
   PubMedGoogle Scholar
• Dichiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes 2007;56(12):3014. doi:10.2337/db07-0707
   PubMed Web of Science ®Google Scholar
• Paniccia R, Priora R, Alessandrello Liotta A, Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag 2015;2015(default):133–148. doi:10.2147/VHRM.S44469
   Google Scholar
• Gresele P, Harrison P, Bury L, Falcinelli E, Gachet C, Hayward CP, Kenny D, Mezzano D, Mumford AD, Nugent D, et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost 2014;12(9):1562–1569. doi:10.1111/jth.12650
   PubMed Web of Science ®Google Scholar
• Schrör K. Acetylsalicylic Acid, 2nd. Weinheim (DE): John Wiley & Sons Incorporated; 2016.
   Google Scholar
• Cai G, Zhou W, Lu Y, Chen P, Lu Z, Fu Y. Aspirin resistance and other aspirin-related concerns. Off J Italian Neurol Soc 2016;37(2):181–189
   Google Scholar
• Olechowski B, Ashby A, Mariathas M, Khanna V, Mahmoudi M, Curzen N. Is arachidonic acid stimulation really a test for the response to aspirin? Time to think again? Expert Rev Cardiovasc Ther 2017;15(1):35–46. doi:10.1080/14779072.2017.1266255
   PubMed Web of Science ®Google Scholar
• Creative Diagnostics. Aspirin-effect detection ELISA kit (Document no: DEIA6230). 2019. [cited 2021 Jan 12]. Available: http://img.creative-diagnostics.com/pdf/DEIA6230,Aspirin.pdf.
   Google Scholar
• Temperilli F, Rina A, Massimi I, Montemari AL, Guarino ML, Zicari A, Pulcinelli FM. Arachidonic acid-stimulated platelet tests: identification of patients less sensitive to aspirin treatment. Platelets 2015;26(8):783–787. doi:10.3109/09537104.2014.1003291
   PubMed Web of Science ®Google Scholar
• Lopez LR, Guyer KE, De Le Torre IG, Pitts KR, Matsuura E, Ames PR. Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. World J Diabetes 2014;5(2):115–127. doi:10.4239/wjd.v5.i2.115
   PubMedGoogle Scholar
• Cattaneo M. Laboratory detection of ‘aspirin resistance’: what test should we use (if any)? Eur Heart J 2007;28(14):1673–1675. doi:10.1093/eurheartj/ehm232
   PubMed Web of Science ®Google Scholar
• Mansour K, Taher AT, Musallam KM, Alam S. Aspirin resistance. Adv Hematol 2009;2009:1–10. doi:10.1155/2009/937352
   Google Scholar
• Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28(14):1702–1708. doi:10.1093/eurheartj/ehm226
   PubMed Web of Science ®Google Scholar
• Beshay JE, Morgan H, Madden C, Yu W, Sarode R. Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients: a review. J Neurosurg 2010;112(2):307–318. doi:10.3171/2009.7.JNS0982
   PubMed Web of Science ®Google Scholar
• Hayward CPM, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet function analyzer (PFA)‐100 ® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006;4(2):312–319. doi:10.1111/j.1538-7836.2006.01771.x
   PubMed Web of Science ®Google Scholar
• Mani H, Linnemann B, Luxembourg B, Kirchmayr K, Lindhoff-Last E. Response to aspirin and clopidogrel monitored with different platelet function methods. Platelets 2006;17(5):303–310. doi:10.1080/09537100600746524
   PubMed Web of Science ®Google Scholar
• Can MM, Tanboğa IH, Türkyilmaz E, Karabay CY, Akgun T, Koca F, Tokgoz HC, Keles N, Ozkan A, Bezgin T, et al. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays. Thromb Res 2010;125(4):e132. doi:10.1016/j.thromres.2009.11.005
   PubMed Web of Science ®Google Scholar
• VerifyNow® System. User manual California: Accu metrics; 2006. [cited 2021]. Available: https://bchcicu.org/wp-content/uploads/2018/07/0600219870002___20110920.pdf.
   Google Scholar
• Sisodia P, Bhatia R. Aspirin resistance and stroke. J Stroke Med 2018;1(1):19–27. doi:10.1177/2516608518777017
   Google Scholar
• Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin “resistance”. J Am Coll Cardiol 2009;53(8):667–677. doi:10.1016/j.jacc.2008.10.047
   PubMed Web of Science ®Google Scholar
• Barale C, Cavalot F, Frascaroli C, Bonomo K, Morotti A, Guerrasio A, Russo I. Association between high on-aspirin platelet reactivity and reduced superoxide dismutase activity in patients affected by type 2 diabetes mellitus or primary hypercholesterolemia. Int J Mol Sci 2020;21(14):1–18. doi:10.3390/ijms21144983
   Web of Science ®Google Scholar